The importance of the innate immune system in controlling HIV infection and disease.
暂无分享,去创建一个
[1] F. Hecht,et al. SOCIAL CONTACTS AND LEUKÆMIA-LYMPHOMA: THE PHILADELPHIA CHROMOSOME REARRANGEMENT , 1975, The Lancet.
[2] D. Nixon,et al. Cytotoxic T-cell recognition of HIV proteins and peptides. , 1991, AIDS.
[3] C. Heusser,et al. Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells , 1993, The Journal of experimental medicine.
[4] J. Levy,et al. Do beta-chemokines have clinical relevance in HIV infection? , 1997, The Journal of clinical investigation.
[5] R. Siliciano,et al. Preventing AIDS But Not HIV-1 Infection with a DNA Vaccine , 2000, Science.
[6] M. Caligiuri,et al. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. , 1998, Journal of immunology.
[7] S. Pestka,et al. Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes , 1983, International journal of cancer.
[8] A. Svejgaard,et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin , 1997, The Lancet.
[9] A. Syvänen,et al. Contribution of the CCR5 and MBL genes to susceptibility to HIV type 1 infection in the Finnish population. , 1998, AIDS research and human retroviruses.
[10] J. Levy,et al. CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration. , 2000, The Journal of general virology.
[11] R. Steinman,et al. Will the Making of Plasmacytoid Dendritic Cells in Vitro Help Unravel Their Mysteries? , 2000, The Journal of experimental medicine.
[12] T. Lint,et al. Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis , 1990, Journal of virology.
[13] Berger Ea. HIV entry and tropism: the chemokine receptor connection. , 1997 .
[14] R. Kurth,et al. CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] W. Tompkins,et al. Evidence for CD8+ antiviral activity in cats infected with feline immunodeficiency virus , 1996, Journal of virology.
[16] E. Collisson,et al. Anti-Feline Immunodeficiency Virus (FIV) Soluble Factor(s) Produced from Antigen-Stimulated Feline CD8+ T Lymphocytes Suppresses FIV Replication , 2000, Journal of Virology.
[17] S. Pillai,et al. Innate immunity. , 1996, Current opinion in immunology.
[18] Yufei Wang,et al. The role of γ δ T cells in generating antiviral factors and β‐chemokines in protection against mucosal simian immunodeficiency virus infection , 2000 .
[19] M. Moriuchi,et al. Class I-unrestricted noncytotoxic anti-HTLV-I activity of CD8(+) T cells. , 2000, Blood.
[20] J. Sullivan,et al. The human uniqueness of HIV: innate immunity and the viral Tat protein. , 1999, Human immunology.
[21] F. Gheyas,et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. , 2001, Blood.
[22] K. Sell,et al. Inhibition of SIV/SMM replication in vitro by CD8+ cells from SIV/SMM infected seropositive clinically asymptomatic sooty mangabeys. , 1990, Journal of medical primatology.
[23] S. Bartz,et al. γδ T lymphocyte responses to HIV , 1996 .
[24] J. Levy,et al. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. , 1998, Blood.
[25] N. Kadowaki,et al. Reciprocal control of T helper cell and dendritic cell differentiation. , 1999, Science.
[26] A. Simon,et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. , 2000, Science.
[27] M. Biffi,et al. References Subscriptions Permissions Email Alerts The Role of Stat4 in Species-Specific Regulation of Th Cell Development by Type I , 2013 .
[28] J. Margolick,et al. HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. , 1996, Journal of immunology.
[29] J L Sullivan,et al. Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.
[30] S. Knight. Bone-marrow-derived dendritic cells and the pathogenesis of AIDS. , 1996, AIDS.
[31] J. Levy,et al. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. , 1986, Science.
[32] J. Banchereau,et al. Flt3-Ligand and Granulocyte Colony-Stimulating Factor Mobilize Distinct Human Dendritic Cell Subsets In Vivo1 , 2000, The Journal of Immunology.
[33] F. Poccia,et al. Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. , 1999, The Journal of infectious diseases.
[34] J. Skurnick,et al. Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[35] E. R. Stiehm,et al. Deficient polymorphonuclear cell and mononuclear cell antibody-dependent cellular cytotoxicity in pediatric and adult human immunodeficiency virus infection. , 1992, The Journal of infectious diseases.
[36] D. Dripps,et al. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. , 1995, The Journal of clinical investigation.
[37] J. Andersson,et al. Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. , 2001, The Journal of clinical investigation.
[38] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[39] H. Ms,et al. Interferon and human immunodeficiency virus infection. , 1987 .
[40] D. Cooper,et al. CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia. , 1999, The Journal of infectious diseases.
[41] N. Letvin,et al. Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. , 1988, Journal of immunology.
[42] Charles R. Brown,et al. Wide Range of Viral Load in Healthy African Green Monkeys Naturally Infected with Simian Immunodeficiency Virus , 2000, Journal of Virology.
[43] K. Rosenthal,et al. Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific. , 1995, AIDS research and human retroviruses.
[44] J. Levy,et al. Suppression of human immunodeficiency virus replication by CD8+ cells from infected and uninfected chimpanzees. , 1991, Cellular immunology.
[45] Y. Rivière,et al. CD8+-Cell Antiviral Factor Activity Is Not Restricted to Human Immunodeficiency Virus (HIV)-Specific T Cells and Can Block HIV Replication after Initiation of Reverse Transcription , 2000, Journal of Virology.
[46] R. Coombs,et al. Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system. , 1992, The Journal of clinical investigation.
[47] C. Biron,et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.
[48] Y. Monczak,et al. Brief report: Killer cell defect and persistent immunological abnormalities in two patients with chronic active epstein‐barr virus infection , 1989, Journal of medical virology.
[49] M. Daucher,et al. Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[50] J. Levy,et al. Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. , 1996, Immunology today.
[51] C. Bogdan. The function of type I interferons in antimicrobial immunity. , 2000, Current opinion in immunology.
[52] K. Rosenthal,et al. Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease , 1994, Clinical and experimental immunology.
[53] R. Modlin. Immunology: A Toll for DNA vaccines , 2000, Nature.
[54] J. Levy,et al. CD8+ cells from HIV‐2‐infected baboons control HIV replication , 1997, AIDS.
[55] K. Lennert,et al. T-ASSOCIATED PLASMA-CELLS , 1975, The Lancet.
[56] B. Sha,et al. Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. , 1996, Journal of immunology.